BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 1833311)

  • 1. Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis.
    Gruschwitz M; Sepp N; Kofler H; Wick G
    Immunobiology; 1991 Jun; 182(3-4):234-55. PubMed ID: 1833311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HLA class II antigens on skin fibroblasts in scleroderma.
    Branchet MC; Boisnic S; Blétry O; Robert L; Charron D; Francès C
    Br J Dermatol; 1992 May; 126(5):431-5. PubMed ID: 1610682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis.
    Andrews BS; Friou GJ; Barr RJ; Mirick GR; Berman M; Sandborg C; Ross PA
    J Rheumatol; 1986 Apr; 13(2):341-8. PubMed ID: 2941574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-gamma and tumor necrosis factor alpha in the early disease stage.
    Gruschwitz MS; Vieth G
    Arthritis Rheum; 1997 Mar; 40(3):540-50. PubMed ID: 9082943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class II antigen expression in normal human epidermis.
    Carr MM; McVittie E; Guy K; Gawkrodger DJ; Hunter JA
    Immunology; 1986 Oct; 59(2):223-7. PubMed ID: 2429921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts.
    Otsuka A; Hanafusa T; Miyagawa J; Kono N; Tarui S
    Immunopharmacol Immunotoxicol; 1991; 13(3):263-80. PubMed ID: 1834724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
    Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
    Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential MHC class II expression on human peripheral blood monocytes and dendritic cells.
    Brooks CF; Moore M
    Immunology; 1988 Feb; 63(2):303-11. PubMed ID: 3350576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MHC class I and class II antigens in pancreatic adenocarcinomas.
    Scupoli MT; Sartoris S; Tosi G; Ennas MG; Nicolis M; Cestari T; Zamboni G; Martignoni G; Lemoine NR; Scarpa A; Accolla RS
    Tissue Antigens; 1996 Oct; 48(4 Pt 1):301-11. PubMed ID: 8946684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial cell class II major histocompatibility complex molecule expression in stereotactic brain biopsies of patients with acute inflammatory/demyelinating conditions.
    van der Maesen K; Hinojoza JR; Sobel RA
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):346-58. PubMed ID: 10218630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.
    Collins T; Korman AJ; Wake CT; Boss JM; Kappes DJ; Fiers W; Ault KA; Gimbrone MA; Strominger JL; Pober JS
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4917-21. PubMed ID: 6431411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class II antigen expression is increased in different forms of urticaria.
    Haas N; Iwen W; Grabbe J; Uchanska-Ziegler B; Czarnetzki BM
    Int Arch Allergy Immunol; 1996 Feb; 109(2):177-82. PubMed ID: 8563493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human dermal fibroblasts present tetanus toxoid antigen to antigen-specific T cell clones.
    Umetsu DT; Pober JS; Jabara HH; Fiers W; Yunis EJ; Burakoff SJ; Reiss CS; Geha RS
    J Clin Invest; 1985 Jul; 76(1):254-60. PubMed ID: 3160726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class II MHC molecules are specific receptors for staphylococcus enterotoxin A.
    Mollick JA; Cook RG; Rich RR
    Science; 1989 May; 244(4906):817-20. PubMed ID: 2658055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells.
    Meunier L; Gonzalez-Ramos A; Cooper KD
    J Immunol; 1993 Oct; 151(8):4067-80. PubMed ID: 8409386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
    Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
    Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of MHC class II expression on human basophils is dependent on antibody specificity but independent of atopic disposition.
    Poulsen BC; Poulsen LK; Jensen BM
    J Immunol Methods; 2012 Jul; 381(1-2):66-9. PubMed ID: 22546486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.
    Momburg F; Koretz K; Von Herbay A; Möller P
    Clin Exp Immunol; 1988 Jun; 72(3):367-72. PubMed ID: 3048805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.